4//SEC Filing
Yoshiyama Annie 4
Accession 0001835208-25-000007
CIK 0001737287other
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 5:28 PM ET
Size
5.2 KB
Accession
0001835208-25-000007
Insider Transaction Report
Form 4
Yoshiyama Annie
SVP, Finance
Transactions
- Sale
Common Stock
2025-04-21$1.41/sh−9,601$13,537→ 130,663 total
Footnotes (2)
- [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Includes 2274 shares of the Issuer's common stock acquired by the reporting person on March 14, 2025 pursuant to an employee stock purchase program.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001835208
Filing Metadata
- Form type
- 4
- Filed
- Apr 22, 8:00 PM ET
- Accepted
- Apr 23, 5:28 PM ET
- Size
- 5.2 KB